Patents

US 12630864 B2: Methods of nucleic acid sample preparation

Granted
2026-05-19
Filed
2022-05-17 application 17746191
Type
Utility · 20 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Aspects of the technology disclosed herein relate to methods of preparing and analyzing nucleic acids, e.g., cfDNA, and nucleic acids encoding immune receptors and immunoglobulins. In some embodiments, methods for preparing nucleic acids for sequence analysis (e.g., using next-generation sequencing) are provided herein.

Source: PTBLXML, file of 2026-05-19 (ipgb20260519.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Laboratory Corporation of America Holdings 128 patentsUS company or organizationBurlington, NCPTBLXML, file of 2026-05-19

Inventors

InventorPlacePatentsPerson pageSource
Joshua StahlBoulder, COPTBLXML, file of 2026-05-19
Jason MyersBoulder, COPTBLXML, file of 2026-05-19
Brady CulverAliso Viejo, CAPTBLXML, file of 2026-05-19
Brian KudlowBoulder, COPTBLXML, file of 2026-05-19
Jens EberleinBoulder, COPTBLXML, file of 2026-05-19

CPC categories

SubclassCategoryFirst groupSource
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/6813PTBLXML, file of 2026-05-19
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/02PTBLXML, file of 2026-05-19
C07KPeptidesC07K16/2809PTBLXML, file of 2026-05-19
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/09PTBLXML, file of 2026-05-19
C07DHeterocyclic compoundsC07D495/04PTBLXML, file of 2026-05-19

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-12-09Assignment
Assignment of assignor's interest
ARCHERDX, LLC signed 2024-08-04INVITAE CORPORATION SAN FRANCISCO, CA73152/127PASDL, file of 2026-10-15
2024-08-30Assignment
Assignment of assignor's interest
INVITAE CORPORATION signed 2024-08-05LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON, NC68822/25PASDL, file of 2026-10-15
2024-07-25Merger
Merger and change of name
ARCHERDX, INC. signed 2020-10-02
APOLLO MERGER SUB B LLC signed 2020-10-02
ARCHERDX, LLC SAN FRANCISCO, CA68082/202PASDL, file of 2026-10-15
2023-10-12Assignment
Assignment of assignor's interest
STAHL, JOSHUA signed 2019-05-09
MYERS, JASON signed 2019-05-09
CULVER, BRADY signed 2019-05-14
KUDLOW, BRIAN signed 2019-05-14
EBERLEIN, JENS signed 2019-10-02
ARCHERDX, INC. BOULDER, CO65220/357PASDL, file of 2026-10-15
2023-03-07Security interest Security interest
Security interest
ARCHERDX, LLC signed 2023-03-07U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT ST. PAUL, MN62908/442PASDL, file of 2026-10-15
2023-03-07Security interest Security interest
Security interest
ARCHERDX, LLC signed 2023-03-07U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT ST. PAUL, MN62908/95PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.